The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The enduring negative effects of financial toxicity in young adult cancer survivors.
 
Bridgette Thom
Stock and Other Ownership Interests - Adma Pharma (I); Aduro Biotech (I); Arcus Biosciences (I); Avadel Pharmaceuticals (I); Avidity Biosciences (I); Axonics Modulation Technologies (I); Caladrius Biosciences (I); Chimerix (I); Chinook Therapeutics (I); Concert Pharmaceuticals (I); Curis (I); DermTech (I); Halozyme (I); IMV (I); Iovance Biotherapeutics (I); Lipocine (I); Mallinckrodt (I); Mediwound (I); MEI Pharma (I); OncoSec (I); Oncternal Therapeutics (I); Processa Pharmaceuticals (I); Qiagen (I); Revance Therapeutics (I); Sierra Oncology (I); Stemline Therapeutics (I); Sutro Biopharma (I); Zimmer BioMet (I)
 
Catherine Benedict
No Relationships to Disclose
 
Danielle Novetsky Friedman
Consulting or Advisory Role - Fennec Pharma
 
Samantha Watson
No Relationships to Disclose
 
Michelle Zeitler
No Relationships to Disclose
 
Fumiko Chino
Research Funding - Varian Medical Systems (Inst)